echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Adv Skin Wound Care: Sanyrene liquid dressing is effective in reducing the incidence of radiation dermatitis

    Adv Skin Wound Care: Sanyrene liquid dressing is effective in reducing the incidence of radiation dermatitis

    • Last Update: 2022-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Radiotherapy is an important treatment for malignant tumors, but about 95% of patients will develop radiation dermatitis (RD) after radiotherapy, which seriously affects the quality of life and clinical efficacy
    of patients.
    The highest incidence of RD is in patients with
    malignancies of the head and neck and breast.
    Sanyrene (Urgo Medical) is a topical skin-protective liquid dressing
    .
    A meta-analysis published in Adv Skin Wound Care evaluated the effectiveness
    of Sanyrene liquid dressing (Urgo Medical) in preventing RD in cancer patients after radiation therapy.

    The researchers searched China National Knowledge Infrastructure, SinoMed, Wanfang Data, PubMed, Web of Science, EMBASE, and Cochrane Library databases for relevant articles
    up to January 2021.

     

    A preliminary search identified a total of 146 studies
    .
    After removing duplicates, applying exclusion criteria, and screening and abstracting, 19 studies including 1,508 patients
    met the inclusion criteria.
    Two reviewers independently screened studies, extracted data, and assessed the risk
    of bias of included studies.

     

    Results showed that Sanyrene reduced the overall incidence of RD (OR, 5.
    00; 95% CI, 2.
    77-9.
    03; P < 0.
    00001), and RD grade 2 (OR, 0.
    Incidence
    of 55; 95% CI, 0.
    36-0.
    85; P = 0.
    007), grade 3 (OR, 0.
    22; 95% CI, 0.
    09-0.
    57; P = 0.
    002), and grade 4 (OR, 0.
    32; 95% CI, 0.
    13-0.
    78; P = 0.
    01).
    。 In addition, Sanyrene liquid dressing improved cure rates (OR, 8.
    18; 95% CI, 4.
    03-16.
    60; P < 0.
    00001) and delayed the onset of RD (mean difference, 3.
    69; 95% CI, 3.
    03-4.
    36; P < 0.
    00001)
    compared to control.

    Taken together, the results of the study suggest that Sanyrene liquid dressing can reduce the overall incidence of RD and the incidence
    of grade 2 and above RD.
    It also improves cure rates and delays the onset
    of RD.
    Therefore, Sanyrene may be a superior option
    for preventing RD after radiation therapy.
    However, the findings were assessed as moderate- to low-quality evidence, and more high-quality trials are needed to support this finding
    .

     

    Original source:

     

    Siqing Li, et al.
    , The Effect of Sanyrene Liquid Dressing in Preventing Radiation Dermatitis: A Systematic Review and Meta-analysis.
    Adv Skin Wound Care.
    2022 Nov 1; 35(11):1-8.
    doi: 10.
    1097/01.
    ASW.
    0000889852.
    91765.
    ad.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.